Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
Betsy Kohler, Recinda Sherman, Nadia Howlader, et al.
JNCI Journal of the National Cancer Institute (2015) Vol. 107, Iss. 6
Open Access | Times Cited: 840

Showing 1-25 of 840 citing articles:

Cancer statistics, 2019
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal
CA A Cancer Journal for Clinicians (2019) Vol. 69, Iss. 1, pp. 7-34
Open Access | Times Cited: 18940
Breast cancer statistics, 2019
Carol DeSantis, Jiemin Ma, Mia M. Gaudet, et al.
CA A Cancer Journal for Clinicians (2019) Vol. 69, Iss. 6, pp. 438-451
Open Access | Times Cited: 2845
Breast cancer
Nadia Harbeck, Frédérique Penault‐Llorca, Javier Cortés, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 2284
Breast Cancer Statistics, 2022
Angela N. Giaquinto, Hyuna Sung, Kimberly D. Miller, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 6, pp. 524-541
Open Access | Times Cited: 1727
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
James L. Mohler, Emmanuel S. Antonarakis, Andrew J. Armstrong, et al.
Journal of the National Comprehensive Cancer Network (2019) Vol. 17, Iss. 5, pp. 479-505
Open Access | Times Cited: 1436
Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
Ahmedin Jemal, Elizabeth Ward, Christopher J. Johnson, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 9
Open Access | Times Cited: 1402
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Kathleen A. Cronin, Andrew Lake, Susan Scott, et al.
Cancer (2018) Vol. 124, Iss. 13, pp. 2785-2800
Open Access | Times Cited: 1360
Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review
Sergiusz Łukasiewicz, Marcin Czeczelewski, Alicja Forma, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4287-4287
Open Access | Times Cited: 1175
Estimated Projection of US Cancer Incidence and Death to 2040
Lola Rahib, Mackenzie R. Wehner, Lynn M. Matrisian, et al.
JAMA Network Open (2021) Vol. 4, Iss. 4, pp. e214708-e214708
Open Access | Times Cited: 948
Annual Report to the Nation on the Status of Cancer, 1975‐2012, featuring the increasing incidence of liver cancer
A. Blythe Ryerson, Christie R. Eheman, Sean F. Altekruse, et al.
Cancer (2016) Vol. 122, Iss. 9, pp. 1312-1337
Open Access | Times Cited: 912
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Ingrid A. Mayer, Linda T. Vahdat, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 8, pp. 741-751
Open Access | Times Cited: 722
Worldwide burden of colorectal cancer: a review
Pasqualino Favoriti, Gabriele Carbone, Marco Greco, et al.
Updates in Surgery (2016) Vol. 68, Iss. 1, pp. 7-11
Closed Access | Times Cited: 655
The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies
Joseph M. Unger, Elise D. Cook, Eric Tai, et al.
American Society of Clinical Oncology Educational Book (2016), Iss. 36, pp. 185-198
Open Access | Times Cited: 496
Precision Public Health for the Era of Precision Medicine
Muin J. Khoury, Michael F. Iademarco, William T. Riley
American Journal of Preventive Medicine (2015) Vol. 50, Iss. 3, pp. 398-401
Open Access | Times Cited: 488
Differences in Breast Cancer Survival by Molecular Subtypes in the United States
Nadia Howlader, Kathleen A. Cronin, Allison W. Kurian, et al.
Cancer Epidemiology Biomarkers & Prevention (2018) Vol. 27, Iss. 6, pp. 619-626
Closed Access | Times Cited: 466
Social determinants of breast cancer risk, stage, and survival
Steven S. Coughlin
Breast Cancer Research and Treatment (2019) Vol. 177, Iss. 3, pp. 537-548
Closed Access | Times Cited: 457
The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer
Maryann Kwa, Claudia S. Plottel, Martin J. Blaser, et al.
JNCI Journal of the National Cancer Institute (2016)
Open Access | Times Cited: 450
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
Edward M. Schaeffer, Sandy Srinivas, Emmanuel S. Antonarakis, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 2, pp. 134-143
Open Access | Times Cited: 441
Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992–2013
Anne‐Michelle Noone, Kathleen A. Cronin, Sean F. Altekruse, et al.
Cancer Epidemiology Biomarkers & Prevention (2016) Vol. 26, Iss. 4, pp. 632-641
Open Access | Times Cited: 379
Triple‑negative breast cancer therapy: Current and future perspectives (Review)
Kwang‐Ai Won, Charles Spruck
International Journal of Oncology (2020) Vol. 57, Iss. 6, pp. 1245-1261
Open Access | Times Cited: 362
The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies
Joseph M. Unger, Elise D. Cook, Eric Tai, et al.
American Society of Clinical Oncology Educational Book (2016) Vol. 36, pp. 185-198
Open Access | Times Cited: 359
Endocrine resistance in breast cancer – An overview and update
Robert Clarke, John J. Tyson, J. Michael Dixon
Molecular and Cellular Endocrinology (2015) Vol. 418, pp. 220-234
Open Access | Times Cited: 319
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study
Kenji Tamura, Junji Tsurutani, Shunji Takahashi, et al.
The Lancet Oncology (2019) Vol. 20, Iss. 6, pp. 816-826
Closed Access | Times Cited: 315
Environmental effects of ozone depletion, UV radiation and interactions with climate change: UNEP Environmental Effects Assessment Panel, update 2017
Alkiviadis Bais, Robyn Lucas, Janet F. Bornman, et al.
Photochemical & Photobiological Sciences (2018) Vol. 17, Iss. 2, pp. 127-179
Open Access | Times Cited: 313
Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma
Felix J. Hüttner, Christina Fitzmaurice, Guido Schwarzer, et al.
Cochrane library (2016) Vol. 2016, Iss. 2
Open Access | Times Cited: 287
Page 1 - Next Page

Scroll to top